| Serial Number | 87364438 |
| Word Mark | UNIVERSAL FUSION EXPRESSION |
| Filing Date | Thursday, March 9, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, September 26, 2025 |
| Registration Number | 5699440 |
| Registration Date | Tuesday, March 12, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; oncology reference laboratory testing services for diagnostic or treatment purposes |
| Goods and Services | Genetic mapping for scientific purposes; genetic mapping for scientific purposes, namely, gene sequencing; medical research, namely, molecular sequencing; cancer study and analysis; clinical study and testing of cells for medical research purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing scientific and medical research information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, and clinical study and testing of cells; scientific testing and research services and clinical scientific testing in the fields of oncology, pathology, gene sequencing, molecular sequencing, human disease and human medical conditions; providing an Internet website portal featuring scientific and medical research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; providing temporary use of online non-downloadable software for enhancement of analysis, research and review of information pertaining to medical, scientific and genetic testing and analysis, and for providing information pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; software as a service (SAAS) featuring software for enhancement of analysis, research and review of information pertaining to medical, scientific and genetic testing and analysis, and for providing information pertaining to such testing and analysis; providing medical research and scientific research information in the field of oncology; scientific and medical research in the field of genetic testing, RNA testing and sequencing; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for medical research services in the field of human disease and human medical conditions; clinical research laboratory services in the field of human disease, human medical conditions, and oncology reference laboratory services for medical research purposes; providing scientific and medical research information, interactive information, and reports to others in the fields of pathology, diagnostic testing and oncology testing |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 26, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, March 30, 2017 |
| First Use In Commerce Date | Thursday, March 30, 2017 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, September 26, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, March 30, 2017 |
| First Use In Commerce Date | Thursday, March 30, 2017 |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Fort Myers, FL 33912 |
| Party Name | NeoGenomics Laboratories, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Naples, FL 34103 |
| Event Date | Event Description |
| Monday, March 13, 2017 | NEW APPLICATION ENTERED |
| Tuesday, March 14, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, June 4, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, June 13, 2017 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 13, 2017 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 13, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 13, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 18, 2018 | FINAL REFUSAL WRITTEN |
| Thursday, December 21, 2017 | ASSIGNED TO LIE |
| Wednesday, December 27, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 27, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 18, 2018 | FINAL REFUSAL E-MAILED |
| Thursday, January 18, 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, July 11, 2018 | TEAS AMENDMENT OF USE RECEIVED |
| Thursday, July 12, 2018 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, July 12, 2018 | USE AMENDMENT FILED |
| Thursday, July 12, 2018 | AMENDMENT TO USE PROCESSING COMPLETE |
| Saturday, July 14, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, July 14, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 18, 2018 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, July 18, 2018 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Wednesday, July 18, 2018 | EX PARTE APPEAL-INSTITUTED |
| Monday, August 6, 2018 | USE AMENDMENT ACCEPTED |
| Tuesday, August 7, 2018 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Tuesday, August 7, 2018 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Tuesday, August 7, 2018 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, August 7, 2018 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, August 7, 2018 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Friday, January 25, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 25, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, January 26, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 29, 2019 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Tuesday, January 29, 2019 | EXPARTE APPEAL TERMINATED |
| Tuesday, February 5, 2019 | ASSIGNED TO LIE |
| Wednesday, February 6, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, March 12, 2019 | REGISTERED-SUPPLEMENTAL REGISTER |
| Thursday, November 10, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, July 3, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Monday, June 13, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 13, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 13, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 10, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, November 10, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, November 10, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 10, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 1, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, September 26, 2025 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, March 12, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, February 1, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, February 1, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 1, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 1, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |